In this study, we used system serology to characterize the SARS-CoV-2 isotype, subclass, FcR binding, and Fc-mediated functional activity of CP units administered to 19 hospitalized COVID-19 patients and pre- and post-CP administration plasma of the recipients (Supplementary Fig. 1A). The gene discussed is CP; the disease is COVID-19.